Adverse Events Clinical Trials in Beijing, Beijing Municipality
3 recruitingBeijing, Beijing Municipality, China
Showing 1–3 of 3 trials
Recruiting
Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Immune-related Adverse Events
Peking Union Medical College Hospital500 enrolled1 locationNCT07453342
Recruiting
Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients
PD-1Immune-related Adverse Events
Guohui Li100 enrolled1 locationNCT04840355
Recruiting
Phase 2
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Cervical CarcinomaImmunotherapyImmune Checkpoint Inhibitor+6 more
Lei Li92 enrolled1 locationNCT05311566